Primary Osteogenic Sarcoma of the Femur: A Model for the Use of Preoperative Chemotherapy in High Risk Malignant Tumors

References

• Jaffe N: Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30: 1627-1631, 1972.
   Web of Science ®Google Scholar
• Sutow WW, Gehan EA, Dyment PA, et al: Multidrug adjuvant chemotherapy for osteogenic sarcoma. Interim report of the Southwest Oncology Group studies. Cancer Treat Rep 62:265–270, 1978.
   PubMedGoogle Scholar
• Pratt CB, Howarth C, Ransom JL, et al: High-dose methotrexate alone and in combination therapy for measurable primary or metastatic osteogenic sarcoma. Cancer Treat Rep 64: 11–20, 1980.
   PubMedGoogle Scholar
• Pratt CB: Chemotherapy of osteosarcoma. An overview. Therapeutic Progress in Ovarian Cancer. Testicular Cancer and the Sarcomas, In van Oosterom AT, Muggia FM, Cleton FJ, Eds: Martinus Nijhoff Publishers, The Hague, 1980, pp 329–348.
   Google Scholar
• Rosen G, Suvanisirikul S, Kwon C, et al: High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma. Cancer 33: 1151–1163, 1974.
   PubMed Web of Science ®Google Scholar
• Rosen G, Huvos AG, Mosende C, et al: Chemotherapy and thoracotomy for metastatic osteogenic sarcoma. A model for adjuvant chemotherapy and the rationale for the timing of thoracic surgery. Cancer 41:841–849, 1978.
   Google Scholar
• Rosen G: Malignant musculoskeletal tumors. The clinical investigative approach to combined therapy. In Care of the Child with Cancer. The American Cancer Society, New York, 1979, pp 73–82.
   Google Scholar
• Rosen G, Murphy ML, Huvos AG, et al: Chemotherapy, en bloc resection and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer 37: I-II, 1976.
   Google Scholar
• Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative chemotherapy based upon the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230, 1982.
   PubMed Web of Science ®Google Scholar
• Mehta BM, Juergens H, Allen JC, Rosen G, Hutchinson DJ: Distribution of methotrexate, citrovorum factor, and5-methyltetrahydrofolate after high dose methotrexate-leucovorin rescue in osteogenic sarcoma. In Current Chemotherapy and Infectious Disease. Proceedings of the lIth International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Nelson JD, Grassi C, Eds: The American Society for Microbiology, Washington, DC, 1980, Vol 2, pp 1635–1636.
   Google Scholar
• Nirenberg A, Mosende C, Mehta BM, Gisolfi AL, Rosen G: High dose methotrexate with citrovorum factor rescue: Predictivevalue of serum methotrexate concentrations and corrective measures to avert toxicity. Cancer Treat Rep 61: 779–783, 1977.
   PubMedGoogle Scholar
• Jaffe N, Frei E, Traggis D, Watts H: Weekly high-dose methotrexate-citrovorum factor in osteogenic sarcoma. Cancer 39:45–50, 1977.
   PubMed Web of Science ®Google Scholar
• Rosen G, Nirenberg A, Juergens H, Caparros B, Huvos AG: Response of primary osteogenic sarcoma to single-agent therapy with high-dose methotrexate with citrovorum factor rescue. In Current Chemotherapy and Infectious Disease. Proceedings of the 1Ith International Congress of Chemotherapy and the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy, Nelson JD, Grassi C, Eds: The American Society for Microbiology, Wishington, DC, 1980, Vol 2, pp 1633–1635.
   Google Scholar
• Mosende C, Guttierez M, Caparros B, Rosen G: Combination chemotherapy with bleomycin, cyclophosphamide and dactinomycin for the treatment of osteogenic sarcoma. Cancer 40:2779–2786, 1977.
   PubMed Web of Science ®Google Scholar
• Rosen G, Nirenberg A, Caparros B, et al: Osteogenic sarcoma: eighty percent, three-year, disease-free survival with combination chemotherapy (T-7). Natl Cancer Inst Mono 56:213–220, 1981.
   PubMedGoogle Scholar
• Huvos AG, Rosen G, Marcove RC: Primary osteogenic sarcoma. Pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101: 14–18, 1977.
   Google Scholar
• Rosen G, Marcove RC, Caparros B, et al: Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163–3177, 1979.
   Google Scholar
• Kamalakar P, Freeman AI, Higby DJ, et al: Clinical response and toxicity with cis-dichloro-diammine-platinum (II) in children. Cancer Treat Rep 61:835–839, 1977.
   PubMedGoogle Scholar
• Ochs JJ, Freeman AI, Douglass HO, et al: cis-Dichlorodiammine-platinum (II) in advanced osteogenic sarcoma. Cancer Treat Rep 62:239–245, 1978.
   PubMedGoogle Scholar
• Rosen G, Nirenberg A, Juergens H, Tan CTC: Phase II trial of cisplatinum in osteogenic sarcoma. Proc Am Assoc Cancer Res 20:363, 1979.
   Web of Science ®Google Scholar
• Pratt CB, Hayes FA, Green AA, et al: Phase II pharmacokinetic study of cis platinum diamrninedichloride (CDDP) in children with solid tumors. Proc Am Assoc Cancer Res 20:361, 1979.
   Web of Science ®Google Scholar
• Cortes EP, Holland JF, Wang JJ. et al: Amputation and adriamycin in primary osteogenic sarcoma. New Engl J Med 291:999–1000, 1974.
   Web of Science ®Google Scholar
• Pratt CB, Shanks EC, Hustu HO, et al: Adjuvant multiple drug chemotherapy for osteogenic sarcoma of the extremity. Cancer 39:51–57, 1977.
   PubMed Web of Science ®Google Scholar
• Sutow WE, Sullivan MP, Wilbur JR, Cangir A: A study of adjuvant chemotherapy osteogenic sarcoma. J Clin Pharmacol 7:530–533, 1975.
   Web of Science ®Google Scholar
• Etcubanas E, Wilbur JR: Adjuvant chemotherapy for osteogenic sarcoma. Cancer Treat Rep 62:283–287, 1978.
   PubMedGoogle Scholar
• Rosenberg SA, Chabner BA, Young RC, et al: Treatment of osteogenic sarcoma. Effect of adjuvant high-dose methotrexate after amputation. Cancer Treat Rep 63:739–751, 1979.
   Google Scholar
• Catane R, Bono VH, Louie AC, Muggia FM: High-dose methotrexate, not a conventional treatment. Cancer Treat Rep 62:178–180, 1978.
   PubMedGoogle Scholar
• Rosenberg SA, Flye MW, Conkle D, et al: Treatment of osteogenic sarcoma. Aggressive resection of pulmonary metastases. Cancer Treat Rep 63:753–756, 1979.
   Google Scholar
• Marcove RC, Mike V, Hajek JV, et al: Osteogenic sarcoma under the age of 21. A review of 145 operative cases. J Bone Joint Surg 52-A:411-423, 1970.
   Web of Science ®Google Scholar
• Marcove RC, Mike V, Hajek JV, et al: Osteogenic sarcoma in childhood. NY State J Med 71:855–859, 1971.
   PubMedGoogle Scholar
• Sims FH, Unni KK, Beabout JW, et al: Osteosarcoma with small cells simulating Ewing's tumor. J Bone Joint Surg 61A:207-215, 1979.
   Google Scholar
• Marcove RC, Rosen G: En bloc resections for osteogenic sarcoma. Natl Cancer Inst Mono 56:165–168, 1981.
   PubMedGoogle Scholar
• Marcove RC: En bloc resection for osteogenic sarcoma. Can J Surg 20:521–528, 1977.
   PubMed Web of Science ®Google Scholar